nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—BCHE—Triamcinolone—ankylosing spondylitis	0.682	1	CbGbCtD
Cinchocaine—CALM3—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.0258	0.0847	CbGpPWpGaD
Cinchocaine—CALM2—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.025	0.0819	CbGpPWpGaD
Cinchocaine—CALM1—Uptake and function of anthrax toxins—ANTXR2—ankylosing spondylitis	0.025	0.0819	CbGpPWpGaD
Cinchocaine—CALM3—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0169	0.0556	CbGpPWpGaD
Cinchocaine—CALM2—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0164	0.0538	CbGpPWpGaD
Cinchocaine—CALM1—Cellular roles of Anthrax toxin—ANTXR2—ankylosing spondylitis	0.0164	0.0538	CbGpPWpGaD
Cinchocaine—CALM3—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0163	0.0536	CbGpPWpGaD
Cinchocaine—CALM1—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0158	0.0519	CbGpPWpGaD
Cinchocaine—CALM2—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0158	0.0519	CbGpPWpGaD
Cinchocaine—Chloroquine—TNF—ankylosing spondylitis	0.013	1	CrCbGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.00444	0.0146	CbGpPWpGaD
Cinchocaine—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.00397	0.013	CbGpPWpGaD
Cinchocaine—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.00384	0.0126	CbGpPWpGaD
Cinchocaine—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—CD79A—ankylosing spondylitis	0.00384	0.0126	CbGpPWpGaD
Cinchocaine—CALM2—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00382	0.0125	CbGpPWpGaD
Cinchocaine—CALM1—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.00382	0.0125	CbGpPWpGaD
Cinchocaine—CALM3—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00367	0.0121	CbGpPWpGaD
Cinchocaine—CALM1—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00355	0.0117	CbGpPWpGaD
Cinchocaine—CALM2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.00355	0.0117	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00306	0.0101	CbGpPWpGaD
Cinchocaine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.00238	0.0078	CbGpPWpGaD
Cinchocaine—CALM3—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00231	0.00757	CbGpPWpGaD
Cinchocaine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.0023	0.00755	CbGpPWpGaD
Cinchocaine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.0023	0.00755	CbGpPWpGaD
Cinchocaine—CALM1—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00223	0.00732	CbGpPWpGaD
Cinchocaine—CALM2—BCR signaling pathway—CD79A—ankylosing spondylitis	0.00223	0.00732	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.00221	0.00724	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.00219	0.0072	CbGpPWpGaD
Cinchocaine—CALM3—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00174	0.00573	CbGpPWpGaD
Cinchocaine—CALM2—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00169	0.00554	CbGpPWpGaD
Cinchocaine—CALM1—Cellular roles of Anthrax toxin—TNF—ankylosing spondylitis	0.00169	0.00554	CbGpPWpGaD
Cinchocaine—CALM3—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00168	0.00551	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00162	0.00533	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00162	0.00533	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00157	0.00516	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00152	0.00499	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.00152	0.00499	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00139	0.00456	CbGpPWpGaD
Cinchocaine—CALM3—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00139	0.00456	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00135	0.00441	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.00135	0.00441	CbGpPWpGaD
Cinchocaine—CALM1—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00134	0.00441	CbGpPWpGaD
Cinchocaine—CALM2—Carbohydrate metabolism—B3GNT2—ankylosing spondylitis	0.00134	0.00441	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—B3GNT2—ankylosing spondylitis	0.000993	0.00326	CbGpPWpGaD
Cinchocaine—CALM3—B Cell Activation—CD79A—ankylosing spondylitis	0.000981	0.00322	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—KIR3DL1—ankylosing spondylitis	0.000954	0.00313	CbGpPWpGaD
Cinchocaine—CALM2—B Cell Activation—CD79A—ankylosing spondylitis	0.000949	0.00312	CbGpPWpGaD
Cinchocaine—CALM1—B Cell Activation—CD79A—ankylosing spondylitis	0.000949	0.00312	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—KIR3DL1—ankylosing spondylitis	0.000923	0.00303	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—KIR3DL1—ankylosing spondylitis	0.000923	0.00303	CbGpPWpGaD
Cinchocaine—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000904	0.00297	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000903	0.00296	CbGpPWpGaD
Cinchocaine—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000875	0.00287	CbGpPWpGaD
Cinchocaine—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	0.000875	0.00287	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000874	0.00287	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000874	0.00287	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CARD9—ankylosing spondylitis	0.00086	0.00282	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000835	0.00274	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CARD9—ankylosing spondylitis	0.000832	0.00273	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CARD9—ankylosing spondylitis	0.000832	0.00273	CbGpPWpGaD
Cinchocaine—CALM3—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000822	0.0027	CbGpPWpGaD
Cinchocaine—CALM2—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000811	0.00266	CbGpPWpGaD
Cinchocaine—CALM1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000811	0.00266	CbGpPWpGaD
Cinchocaine—CALM1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000795	0.00261	CbGpPWpGaD
Cinchocaine—CALM2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000795	0.00261	CbGpPWpGaD
Cinchocaine—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000724	0.00238	CbGpPWpGaD
Cinchocaine—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000701	0.0023	CbGpPWpGaD
Cinchocaine—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.000701	0.0023	CbGpPWpGaD
Cinchocaine—CALM3—Disease—ANTXR2—ankylosing spondylitis	0.000667	0.00219	CbGpPWpGaD
Cinchocaine—CALM2—Disease—ANTXR2—ankylosing spondylitis	0.000646	0.00212	CbGpPWpGaD
Cinchocaine—CALM1—Disease—ANTXR2—ankylosing spondylitis	0.000646	0.00212	CbGpPWpGaD
Cinchocaine—CALM3—Alzheimers Disease—TNF—ankylosing spondylitis	0.000627	0.00206	CbGpPWpGaD
Cinchocaine—CALM1—Alzheimers Disease—TNF—ankylosing spondylitis	0.000607	0.00199	CbGpPWpGaD
Cinchocaine—CALM2—Alzheimers Disease—TNF—ankylosing spondylitis	0.000607	0.00199	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL1R2—ankylosing spondylitis	0.000578	0.0019	CbGpPWpGaD
Cinchocaine—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000578	0.0019	CbGpPWpGaD
Cinchocaine—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000578	0.0019	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL1R2—ankylosing spondylitis	0.000559	0.00183	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL1R2—ankylosing spondylitis	0.000559	0.00183	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—ERAP1—ankylosing spondylitis	0.000548	0.0018	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—HLA-C—ankylosing spondylitis	0.00054	0.00177	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—ERAP1—ankylosing spondylitis	0.00053	0.00174	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—ERAP1—ankylosing spondylitis	0.00053	0.00174	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—HLA-C—ankylosing spondylitis	0.000523	0.00172	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—HLA-C—ankylosing spondylitis	0.000523	0.00172	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000519	0.0017	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—B3GNT2—ankylosing spondylitis	0.000512	0.00168	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000502	0.00165	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.000502	0.00165	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CARD9—ankylosing spondylitis	0.000501	0.00164	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CARD9—ankylosing spondylitis	0.000485	0.00159	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CARD9—ankylosing spondylitis	0.000485	0.00159	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—TNF—ankylosing spondylitis	0.000472	0.00155	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000396	0.0013	CbGpPWpGaD
Cinchocaine—CALM3—Disease—B3GNT2—ankylosing spondylitis	0.000393	0.00129	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000383	0.00126	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.000383	0.00126	CbGpPWpGaD
Cinchocaine—CALM1—Disease—B3GNT2—ankylosing spondylitis	0.000381	0.00125	CbGpPWpGaD
Cinchocaine—CALM2—Disease—B3GNT2—ankylosing spondylitis	0.000381	0.00125	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—TNF—ankylosing spondylitis	0.000332	0.00109	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—B3GNT2—ankylosing spondylitis	0.000329	0.00108	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000323	0.00106	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00032	0.00105	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—HLA-B—ankylosing spondylitis	0.000319	0.00105	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—B3GNT2—ankylosing spondylitis	0.000319	0.00105	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—B3GNT2—ankylosing spondylitis	0.000319	0.00105	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—HLA-C—ankylosing spondylitis	0.000315	0.00103	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000312	0.00102	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000312	0.00102	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000309	0.00102	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000309	0.00102	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—HLA-B—ankylosing spondylitis	0.000309	0.00101	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000309	0.00101	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000307	0.00101	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—HLA-C—ankylosing spondylitis	0.000304	0.000999	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—HLA-C—ankylosing spondylitis	0.000304	0.000999	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000297	0.000974	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000297	0.000974	CbGpPWpGaD
Cinchocaine—CALM3—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000284	0.000933	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—CRP—ankylosing spondylitis	0.000282	0.000927	CbGpPWpGaD
Cinchocaine—CALM1—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000275	0.000902	CbGpPWpGaD
Cinchocaine—CALM2—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000275	0.000902	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL1RN—ankylosing spondylitis	0.000273	0.000897	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—CRP—ankylosing spondylitis	0.000273	0.000897	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—CRP—ankylosing spondylitis	0.000273	0.000897	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—TLR4—ankylosing spondylitis	0.000271	0.000889	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL1RN—ankylosing spondylitis	0.000264	0.000868	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL1RN—ankylosing spondylitis	0.000264	0.000868	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—TLR4—ankylosing spondylitis	0.000262	0.00086	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—TLR4—ankylosing spondylitis	0.000262	0.00086	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD79A—ankylosing spondylitis	0.00024	0.000788	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD79A—ankylosing spondylitis	0.000232	0.000762	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD79A—ankylosing spondylitis	0.000232	0.000762	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000228	0.000747	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00022	0.000723	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00022	0.000723	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—IL1A—ankylosing spondylitis	0.000197	0.000646	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CD40LG—ankylosing spondylitis	0.000196	0.000642	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—IL1A—ankylosing spondylitis	0.00019	0.000625	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—IL1A—ankylosing spondylitis	0.00019	0.000625	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CD40LG—ankylosing spondylitis	0.000189	0.000621	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CD40LG—ankylosing spondylitis	0.000189	0.000621	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000189	0.00062	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—HLA-B—ankylosing spondylitis	0.000186	0.000611	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000183	0.0006	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000183	0.0006	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—HLA-B—ankylosing spondylitis	0.00018	0.000591	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—HLA-B—ankylosing spondylitis	0.00018	0.000591	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—HLA-A—ankylosing spondylitis	0.000172	0.000566	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—HLA-A—ankylosing spondylitis	0.000167	0.000547	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—HLA-A—ankylosing spondylitis	0.000167	0.000547	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—CRP—ankylosing spondylitis	0.000164	0.00054	CbGpPWpGaD
Cinchocaine—CALM3—Disease—HLA-A—ankylosing spondylitis	0.000159	0.000522	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—CRP—ankylosing spondylitis	0.000159	0.000522	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—CRP—ankylosing spondylitis	0.000159	0.000522	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—TLR4—ankylosing spondylitis	0.000158	0.000518	CbGpPWpGaD
Cinchocaine—CALM2—Disease—HLA-A—ankylosing spondylitis	0.000154	0.000505	CbGpPWpGaD
Cinchocaine—CALM1—Disease—HLA-A—ankylosing spondylitis	0.000154	0.000505	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—TLR4—ankylosing spondylitis	0.000153	0.000501	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—TLR4—ankylosing spondylitis	0.000153	0.000501	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000135	0.000442	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—MMP3—ankylosing spondylitis	0.00013	0.000427	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—MMP3—ankylosing spondylitis	0.00013	0.000427	CbGpPWpGaD
